George Mason University Antonin Scalia Law School

Reply and Response to C-IP2’s March 4, 2021, Blogpost on UC Hastings’ Evergreen Drug Patent Search Database

C-IP2’s original post on the UC Hastings’ Evergreen Drug Patent Search Database can be read here.

Reply to Blog Post on UC Hastings’ Evergreen Drug Patent Search Database

Robin Feldman
Arthur J. Goldberg Distinguished Professor of Law
Albert Abramson ’54 Distinguished Professor of Law Chair
Director of the Center for Innovation at University of California Hastings

We would like to thank the author of the blog post for taking the time to look at our work for the Evergreen Drug Patent Database. Read more

Privacy Law Considerations of AI and Big Data – In the U.S. & Abroad

By Kathleen Wills, Esq.*

Kathleen Wills is a graduate of Antonin Scalia Law School and former C-IP2 RA.

circuit boardArtificial Intelligence and Big Data

While many of us have come to rely on biometrics data when we open our phones with Apple’s “Face ID,” speak to Amazon’s Alexa, or scan our fingerprints to access something, it’s important to understand some of the legal implications about the big data feeding artificial intelligence (AI) algorithms. Read more

UC Hastings’ Evergreen Drug Patent Search Database: A Look Behind the Statistics Reveals Problems with this Approach to Identifying and Quantifying So-Called “Evergreening”

pharmaceuticalsThe Center for Innovation, housed at the University of California Hastings College of the Law, has created an Evergreen Drug Patent Search Database (the “Evergreening Database,” or “Database”).[1] The Database was created to address the perceived problem of “evergreening,” which the Database defines as “pharmaceutical company actions that artificially extend the protection horizon, or cliff, of their patents.” Read more